SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories informs about incorporation of wholly owned subsidiary

17 Sep 2024 Evaluate
Pursuant to Regulation 30 of the SEBI LODR Regulations, Alkem Laboratories has informed that a Wholly Owned Subsidiary (WOS) of the Company in the name of ‘Alkem Wellness Limited’ has been incorporated on 16th September, 2024 in India. Particulars of the disclosure required under SEBI LODR Regulations read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 have been provided in Annexure - I.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5583.70 16.00 (0.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×